Trial Profile
The Clinical Efficacy And Subclinical Effects on arterial STIFFNESS of bosentan therapy added to usual care in patients with systemic sclerosis with digital ulcers.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2016
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Systemic scleroderma
- Focus Therapeutic Use
- Acronyms CEASE STIFFNESS
- 14 Apr 2016 New trial record